Skip to main content
< Back
About
About the conference
Latest updates
Organisers & Partners
App
Press room
Programme 19
Full programme
Tracks
Speakers 19
Keynote speakers
All speakers
Side events 19
Venue 19
About the venue
Location
Rooms
Subscribe
Policy
Sessions
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
New psychoactive substances
Alcohol and drug treatment
Cannabis — Policy
Experiences from the south east region of Ireland
Public participation in effective development of a regional drug strategy
Thursday, 08 August
14:20
A mixed methods study to identify the implications for policy and practice
Variations and determinants of novel psychoactive substance use
14:20
Wednesday, 23 October
10:50
Challenges for harm reduction I
10:50
to
12:20
Insights zone 2 (I2)
Meni Malliori
Definition of disorders
10:50
to
12:20
Networking zone 1 (N1)
Viktor Mravčík
Poster guided tour
Progress in alcohol research and responses - EUFAS poster session 1
10:50
to
12:20
Guided poster tours room
Colin Drummond
13:20
Political approaches, tensions and compromises behind a new political consensus
2009-2019 — A crucial decade in international drug policy
13:20
to
14:50
Central square 2 (C2)
Lotta Lampela
European Research Area Network on Illicit Drugs
13:20
to
14:50
Insights zone 4 (I4)
Henk Garretsen
A global network of universities as the future of addiction education
13:20
to
14:50
Insights zone 1 (I1)
Kimberly Johnson
Improving delivery of healthcare programmes
13:20
to
14:50
Central square 3 (C3)
Graça Vilar
Modelling the impact of decriminalisation
13:20
to
14:50
Networking zone 1 (N1)
Rosalie Pacula
15:00
Lessons learned on European supported drug programming towards an effective, inclusive and balanced drug policies in Central Asia countries
Modernisation, stagnation or roll-back
15:00
to
16:30
Networking zone 4 (N4)
John-Peter Kools
Drug policy and human rights
15:00
to
16:30
Insights zone 1 (I1)
João Goulão
18:30
Workforce development and training
18:30
to
19:30
Networking zone 3 (N3)
Andrew Bennet
Consumption rooms: overcoming implementation challenges
18:30
to
19:30
Insights zone 4 (I4)
Ricardo Fuertes
Treatment in the justice system
18:30
to
19:30
Central square 2 (C2)
Sharon Dawe
Thursday, 24 October
10:50
Methods and approaches to inform drug policy and practice
10:50
to
12:20
Networking zone 4 (N4)
Márya Hynes
Lancet review series: Using evidence to better respond to drug problems - a call for action
10:50
to
12:20
Main stage
Pam Das
Alcohol perspectives and prevention - EUFAS poster session 2
10:50
to
12:20
Guided poster tours room
Linn Gjersing
13:20
How to inform policy and decision makers about evidence-based prevention
13:20
to
14:50
Networking zone 2 (N2)
Matej Košir
Cannabis — risks and responses
13:20
to
14:50
Networking zone 4 (N4)
Jennifer Price
Alcohol: harms and policies
13:20
to
14:50
Futures zone 3 (F3)
Virginia Berridge
Infusing policy with evidence
13:20
to
14:50
Central square 3 (C3)
Lara Tavoschi
Policy and treatment
13:20
to
14:50
Insights zone 2 (I2)
Matthew Young
Using new technology and innovative methods to measure substance use and related harm
13:20
to
14:50
Networking zone 1 (N1)
Peter Reuter
15:00
Global changes in cannabis products
15:00
to
16:30
Main stage
Tom Freeman
Wayne Hall
Current trends and future challenges
The cannabis policy kaleidoscope
15:00
to
16:30
Central square 2 (C2)
Nicola Singleton
Drug markets
15:00
to
16:30
Insights zone 4 (I4)
Dirk Korf
16:50
The Swedish ANDT-strategy
How to support the implementation of a comprehensive policy for alcohol, narcotics, doping, and tobacco from a public health perspective
16:50
to
18:20
Insights zone 1 (I1)
Linda Brännström
Alcohol policies and preventions
16:50
to
18:20
Central square 1 (C1)
Antoni Gual
New methods
16:50
to
18:20
Central square 2 (C2)
André Noor
Striving towards the future elimination of Hep C among people who use drugs
16:50
to
18:20
Futures zone 1 (F1)
Eberhard Schatz
Perrine Roux
18:30
Lessons from the field
Measuring and monitoring drug policy for research, surveillance and practice
18:30
to
19:30
Networking zone 1 (N1)
Rosalie Pacula
Nightlife, festivals and other recreational settings
18:30
to
19:30
Networking zone 3 (N3)
Andrew Bennet
Cannabis labelling and health warnings: use and impacts
18:30
to
19:30
Insights zone 4 (I4)
Hanan Abramovici
Prevention science and measurement of demand reduction quality standards
18:30
to
19:30
Central square 1 (C1)
Nicola Singleton
Friday, 25 October
09:00
Studying the operation of new forms of cannabis supply
09:00
to
10:30
Central square 1 (C1)
Caitlin Hughes
Contemporary issues in addictions
09:00
to
10:30
Central square 3 (C3)
Henk Garretsen
10:45
online registration required
Supporting future cannabis policy/achieving a Standard Joint Unit – FuturiZe workshop
10:45
to
12:15
Futures zone 3 (F3)
Antoni Gual
Hugo López-Pelayo
Approaches to support the development of an evaluative culture to promote better drug policy for the future
10:45
to
12:15
Networking zone 2 (N2)
Liesbeth Vandam
Drug policy debates: how are routine monitoring data used?
10:45
to
12:15
Insights zone 2 (I2)
Lies Gremeaux
Alcohol: alcohol use disorder treatment and outreach
10:45
to
12:15
Insights zone 1 (I1)
Colin Drummond
Presentations
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Wednesday, 23 October
10:50
Poster
Exposure to alcohol and/or cadmium changes status of bioelements in rat tests
10:50
to
12:20
Guided poster tours room
Mirjana Djukic
Poster
'Drink to forget' – a case report
10:50
to
12:20
Guided poster tours room
Mariana Lázaro
Poster
Screening for alcohol-related cognitive impairments – a case study
10:50
to
12:20
Guided poster tours room
Luisa Gil
Poster
Neuroprotective role of argan oil against alcohol use disorders in adolescent wistar rat
10:50
to
12:20
Guided poster tours room
Hicham El Mostafi
Poster
Cadmium and/or ethanol increase oxidative stress in liver of the exposed rats
10:50
to
12:20
Guided poster tours room
Mirjana Djukic
Poster
Screening and brief interventions for reducing alcohol consumption in a department of firefighters in the central region of Portugal
10:50
to
12:20
Guided poster tours room
Teresa Barroso
Poster
Court proceedings and actions taken by a probation officer in work with people addicted to alcohol.
10:50
to
12:20
Guided poster tours room
Ewelina Silecka-Marek
Poster
Elderly wellbeing and alcohol - a tricky cocktail
10:50
to
12:20
Guided poster tours room
Jakob Emiliussen
11:00
Oral presentation
Views about the disease and brain disease model of addiction: an international survey of addiction treatment providers in the USA, UK and Australia
11:00
to
11:15
Networking zone 1 (N1)
Anthony Barnett
Oral presentation
Vital signs: the future of the harm reduction model in the National Health Service
11:00
to
11:15
Insights zone 2 (I2)
Marta Borges
11:15
Oral presentation
Reconsidering cannabis dependence
11:15
to
11:30
Networking zone 1 (N1)
Liz Temple
Oral presentation
Harm reduction and public health: the case of Sweden
11:15
to
11:30
Insights zone 2 (I2)
Lena Eriksson
11:30
Oral presentation
Agreement degree with the content of the Substance Addiction Consequences Scale items - The development of a new instrument.
11:30
to
11:45
Networking zone 1 (N1)
Paulo Seabra
Oral presentation
Harm reduction drug policy in Israel: what has and still needs to be accomplished?
11:30
to
11:45
Insights zone 2 (I2)
Hagit Bonny-Noach
11:45
Oral presentation
Characterising people that demanded drug treatment in Catalonia: a cluster analysis
11:45
to
12:00
Networking zone 1 (N1)
Xavier Majó
Oral presentation
Street Support Project: a harm reduction approach to urban health and integration
11:45
to
12:00
Insights zone 2 (I2)
Roberto Pérez Gayo
13:20
Oral presentation
Social learning theory and the globalisation of drug demand reduction education programs
13:20
to
14:50
Insights zone 1 (I1)
Kimberly Johnson
Oral presentation
The systematic mapping survey of academic degree university programs focus on addiction science: up-dated overview
13:20
to
14:50
Insights zone 1 (I1)
Amalie Pavlovská
Oral presentation
Understanding the nature of university-based addiction training programs: results of an international survey
13:20
to
14:50
Insights zone 1 (I1)
Roger Peters
Oral presentation
The role of addiction education programs in the development of national strategies to address drug demand reduction
13:20
to
14:50
Insights zone 1 (I1)
Igor Koutsenok
13:25
Oral presentation
Alama-nightlife: Understanding the dynamics and consequences of young adult substance use pathways, a longitudinal and momentary analysis in the European nightlife scene
13:25
to
13:40
Insights zone 4 (I4)
Margriet van Laar
13:30
Oral presentation
A retrospective analysis of a turbulent decade for drug policy; 2009-2019
13:30
to
13:45
Central square 2 (C2)
Danilo Ballotta
Oral presentation
Models for the decriminalisation, depenalisation and diversion of illicit drug possession: an international realist review
13:30
to
13:45
Networking zone 1 (N1)
Caitlin Hughes
Oral presentation
Balancing welfare and market institutional logics. Procurement regulations for social services, such as addiction treatment, in four Nordic welfare countries
13:30
to
13:45
Central square 3 (C3)
Kerstin Stenius
13:40
Oral presentation
Understanding the interplay between cultural, biological and subjective factors in drug use pathways
13:40
to
13:55
Insights zone 4 (I4)
Reinout Wiers
13:45
Oral presentation
To what extent will the drug-crime nexus remain after drug laws liberalisation? An examination of criminal charges among patients in treatment for cannabis use disorders and controls under varied drug policy regimes
13:45
to
14:00
Networking zone 1 (N1)
Anne Line Bretteville-Jensen
Oral presentation
Can liaison and diversion services increase referral to drug and alcohol treatment?
13:45
to
14:00
Central square 3 (C3)
Kate Morley
Oral presentation
Views, positions and objectives of Russia and like-minded countries
13:45
to
14:00
Central square 2 (C2)
Anna Nazarova
13:55
Oral presentation
ATTUNE: Stimulant users in Europe - a state of the art project, reporting on findings and findings to expect
13:55
to
14:10
Insights zone 4 (I4)
Uwe Verthein
14:00
Oral presentation
Views, positions and objectives of Mexico and like-minded countries to tackle the world drug problem
14:00
to
14:15
Central square 2 (C2)
Diego Simancas
Oral presentation
The law enforcement costs of de facto 'criminalising' drug possession: the Italian experience
14:00
to
14:15
Networking zone 1 (N1)
Davide Fortin
Oral presentation
Treatment in therapeutic communities: the experience of Lisbon and Tagus Valley Region
14:00
to
14:15
Central square 3 (C3)
Elizabete Pereira
14:10
Oral presentation
Sensory processing sensitivity and drug use recovery pathways
14:10
to
14:25
Insights zone 4 (I4)
Judith Homberg
14:15
Oral presentation
A viewpoint from civil society
14:15
to
14:30
Central square 2 (C2)
Marie Nougier
Oral presentation
Introducing a new cannabis decriminalisation policy: The unintentional effects on cannabis perceptions and use among Israeli youth
14:15
to
14:30
Networking zone 1 (N1)
Yossi Harel-Fisch
Oral presentation
The influence of institutional response on the individual's recovery from drug misuse
14:15
to
14:30
Central square 3 (C3)
Carolina Cunha
14:25
Oral presentation
Pathways to addiction recovery: mechanisms of change in the UK, Belgium and the Netherlands
14:25
to
14:40
Insights zone 4 (I4)
David Best
14:30
Comment: The role and relevance of multilateralism
14:30
to
14:45
Central square 2 (C2)
Doris Resch
14:40
Oral presentation
Illicit drug policies and social outcomes: a cross-country analysis
14:40
to
14:50
Insights zone 4 (I4)
Ricardo Gonçalves
15:00
Oral presentation
The current drug situation in the Central Asia
15:00
to
16:30
Networking zone 4 (N4)
Viktor Mravčík
Oral presentation
Results and lessons learned of prevention program to support parents (Closer each other-further from risky behaviours) implemented in Tajikistan and Kazakhstan
15:00
to
16:30
Networking zone 4 (N4)
Janusz Sieroslawski
Boguslawa Bukowska
Oral presentation
The situation of harm reduction and treatment of drug use disorders in public health and in prison system in Central Asia
15:00
to
16:30
Networking zone 4 (N4)
Ingo Michels
Heino Stöver
Oral presentation
Opportunities for supporting modernisation of traditional drug policies in Central Asia
15:00
to
16:30
Networking zone 4 (N4)
John-Peter Kools
15:10
Oral presentation
Drugs policy and Human Rights: Recent trends, developments and challenges at the United Nations
15:10
to
15:25
Insights zone 1 (I1)
Zaved Mahmood
15:25
Oral presentation
Human and sustainable drug policies : the Pompidou Group of the Council of Europe
15:25
to
15:40
Insights zone 1 (I1)
Denis Huber
15:40
Oral presentation
What does it mean to adopt a Human Rights approach to drug policy?
15:40
to
15:55
Insights zone 1 (I1)
Damon Barrett
15:55
Oral presentation
Promoting human rights in UN drug policy: a civil society perspective
15:55
to
16:10
Insights zone 1 (I1)
Marie Nougier
18:30
Short communication
The peer in outreach teams: a specialist among specialists?
18:30
to
18:40
Networking zone 3 (N3)
Maria João Oliveira
Oral presentation
Translating and transferring drug prevention interventions across contexts: Learning from the EPPIC project :‘Exchanging Prevention practices on Polydrug use among youth in Criminal justice systems’ (CJS)
18:30
to
18:45
Central square 2 (C2)
Rachel Herring
Oral presentation
Acceptability and willingness to use a mobile drug consumption room in Lisbon
18:30
to
18:45
Insights zone 4 (I4)
Adriana Curado
18:40
Short communication
The Akan-model: a Norwegian model for preventing and handling alcohol, drugs and gambling problems in the workplace
18:40
to
18:50
Networking zone 3 (N3)
Camilla Lynne Bakkeng
18:45
Oral presentation
Peer recovery specialists in the drug treatment court: impact on participant outcomes from a randomised controlled trial
18:45
to
19:00
Central square 2 (C2)
Steven Belenko
Oral presentation
Drug consumption rooms – from a conceptual framework to a basic institutionalised service. The experience of Germany
18:45
to
19:00
Insights zone 4 (I4)
Ingo Michels
18:50
Short communication
Experiences of marketised welfare organisations among addiction treatment staff in Sweden
18:50
to
19:00
Networking zone 3 (N3)
Jessica Storbjörk
19:00
Short communication
Preparing effective addiction workforce: a challenge from the Czech perspective
19:00
to
19:10
Networking zone 3 (N3)
Amalie Pavlovská
Oral presentation
'My first 48 hours out': continuity of health and psychosocial care for drug users after release from prison in four European countries
19:00
to
19:15
Central square 2 (C2)
Wouter Vanderplasschen
Oral presentation
How to develop a common adherence of all the stakeholders when implementing a drug consumption room?
19:00
to
19:15
Insights zone 4 (I4)
Sanda Samitca
19:10
Short communication
Workforce development: the great paradox for the addictions sector
19:10
to
19:20
Networking zone 3 (N3)
Ann Roche
19:15
Oral presentation
Coercion into addiction treatment and subsequent substance use patterns among people who use illicit drugs in Vancouver, Canada
19:15
to
19:30
Central square 2 (C2)
Andreas Pilarinos
Oral presentation
Against political odds: the establishment of a drug consumption room in Belgium.
19:15
to
19:30
Insights zone 4 (I4)
Freya Vander Laenen
19:20
Short communication
Evidence-based practice and its many competing priorities: a qualitative analysis of substance misuse workers in English third-sector addiction treatment services
19:20
to
19:30
Networking zone 3 (N3)
Robert Calder
Thursday, 24 October
10:50
Poster
Alcohol addiction as a social problem in Ukraine: history of research
10:50
to
12:20
Guided poster tours room
Larysa Klymanska
Poster
The alcohol consumption in the modern Ukraine: tendences and perspecties.
10:50
to
12:20
Guided poster tours room
Larysa Klymanska
Poster
Alcohol and drugs in contemporary school pupils on the verge of adolescence: the Polish experience
10:50
to
12:20
Guided poster tours room
Katarzyna Pawelek
Poster
The role of alcohol in fatal fires in Ireland
10:50
to
12:20
Guided poster tours room
Anne Doyle
Poster
Do parents want to change alcohol legislations to protect their children?
10:50
to
12:20
Guided poster tours room
Marta Zin-Sedek
Poster
Social and context determinants of drinking during working time – Portuguese GPS findings 2017
10:50
to
12:20
Guided poster tours room
Cláudia Urbano
Poster
Sub-groups of tobacco and alcohol co-use trajectories from ages 21 to 32: the Amsterdam growth and health longitudinal study
10:50
to
12:20
Guided poster tours room
Sterling McPherson
Poster
Effects of an alcohol prevention program at sport stadiums: a 2-year follow-up study using pseudopatrons and breath alcohol concentration levels
10:50
to
12:20
Guided poster tours room
Tobias Elgan
Poster
Implementing and evaluating alcohol and drug prevention methods at youth health clinics
10:50
to
12:20
Guided poster tours room
Pia Kvillemo
Oral presentation
Global patterns of opioid use and dependence: population harms, interventions, and future action
10:50
to
12:20
Main stage
Louisa Degenhardt
Oral presentation
Public health implications of legalising the production and sale of cannabis for medicinal and recreational use
10:50
to
12:20
Main stage
Wayne Hall
Oral presentation
Responding to growing global stimulant use: challenges and opportunities
10:50
to
12:20
Main stage
Michael Farrell
Oral presentation
The new psychoactive substance phenomenon: current and future challenges for drug surveillance, control, and public health responses
10:50
to
12:20
Main stage
Amy Peacock
Oral presentation
Discussion and the future
10:50
to
12:20
Main stage
Louisa Degenhardt
Pam Das
Paul Griffiths
Wayne Hall
Michael Farrell
Amy Peacock
Poster
Accessing alcohol drinking influence in workplace – What is the panorama and current innovations in Portugal?
10:50
to
12:20
Guided poster tours room
Duarte Vital Brito
11:00
Short communication
Quantitative and qualitative evidences for better gender-based prevention of adolescent addictive behaviours, with and without substance
11:00
to
11:10
Networking zone 4 (N4)
Patricia Gómez
11:10
Short communication
The European Web Survey on Drugs: patterns of use of new psychoactive substances in Belgium
11:10
to
11:20
Networking zone 4 (N4)
Lies Gremeaux
11:20
Short communication
From chronology to processes: combining biographical interview with episodic analysis in a life story
11:20
to
11:30
Networking zone 4 (N4)
Isabel María Herrera-Sánchez
11:30
Short communication
Coding multiple drug use in ICD-10 and ICD-11
11:30
to
11:40
Networking zone 4 (N4)
Espen Walderhaug
11:40
Short communication
The scientific portrayal of decriminalisation models for psychoactive substances: a scoping review
11:40
to
11:50
Networking zone 4 (N4)
Isabel María Herrera-Sánchez
Short communication
The scientific portrayal of decriminalisation models for psychoactive substances: a scoping review
11:40
to
11:50
Networking zone 4 (N4)
Daniela Filipa Ferreira
11:50
Short communication
The role of the juveniles in the structure and dynamics of the illegal drug market in the Republic of Croatia
11:50
to
12:00
Networking zone 4 (N4)
12:00
Short communication
Lifetime prevalence of drug use before imprisonment in Europe: results from a systematic literature review
12:00
to
12:10
Networking zone 4 (N4)
12:10
Short communication
Public participation in effective development of a regional drug strategy: experiences from the South East region of Ireland
12:10
to
12:20
Networking zone 4 (N4)
Michelle Foley
13:30
Short communication
Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CNR1 receptor and FAAH enzyme
13:30
to
13:40
Networking zone 4 (N4)
Chandni Hindocha
Oral presentation
'A more accurate understanding of drug use': a critical analysis of wastewater analysis technology for drug policy
13:30
to
13:45
Networking zone 1 (N1)
Kari Lancaster
Oral presentation
Development of lower-risk gambling guidelines
13:30
to
13:45
Insights zone 2 (I2)
Matthew Young
Oral presentation
Translating research into policy: is 'advocacy' a dirty word?
13:30
to
13:45
Central square 3 (C3)
Alison Ritter
Oral presentation
Constructing alcohol screening and counselling: the attitudes of social work professionals and their clients
13:30
to
13:45
Futures zone 3 (F3)
Elina Renko
13:40
Short communication
Psychological aspects of cannabis use disorder: a review of the theory and implications for psychotherapy
13:40
to
13:50
Networking zone 4 (N4)
Daniel Feingold
13:45
Oral presentation
Beyond the substances: a multi-criteria analysis of spread of drugs in Europe
13:45
to
14:00
Networking zone 1 (N1)
Giuliano Resce
Oral presentation
Couple treatment of pathological gambling: variables associated with better efficacy
13:45
to
14:00
Insights zone 2 (I2)
Joel Tremblay
Oral presentation
Addiction practitioners and drug policy reform
13:45
to
14:00
Central square 3 (C3)
Kasia Malinowska-Sempruch
Oral presentation
The who, what, where, when and why of adults’ drinking occasions and their association with acute alcohol-related harm: a systematic review
13:45
to
14:00
Futures zone 3 (F3)
Abigail Stevely
13:50
Short communication
Intention to reduce cannabis use and help-seeking attitudes in Dutch frequent cannabis users.
13:50
to
14:00
Networking zone 4 (N4)
Marleen Olthof
14:00
Short communication
Perceptions of effectiveness and believability of pictorial and text-only health warning labels for cannabis products among Canadian youth.
14:00
to
14:10
Networking zone 4 (N4)
Cesar Leos-Toro
Oral presentation
A smartphone app to assess alcohol consumption behaviours: development, validity, compliance and reactivity
14:00
to
14:15
Networking zone 1 (N1)
Rob Hester
Oral presentation
Coping strategies and dysfunctional symptomatoly in pathological gamblers.
14:00
to
14:15
Insights zone 2 (I2)
Paula Jauregui
Oral presentation
Individual vulnerability as core risk factor for gambling disorder: implications for public health and gambling policies
14:00
to
14:15
Central square 3 (C3)
Gerhard Bühringer
Oral presentation
Harmony and dissonance in Swedish intoxication policy
14:00
to
14:15
Futures zone 3 (F3)
Oral presentation
Before rock bottom? Disrupting 'valid denial' amongst harmful drinkers with continuum beliefs
14:00
to
14:15
Futures zone 3 (F3)
James Morris
14:10
Short communication
Cannabis use in early adulthood and later prescription of antipsychotics, mood stabilisers, antidepressants and anxiolytics.
14:10
to
14:20
Networking zone 4 (N4)
Eline Rognli
14:15
Oral presentation
New and fully automated workflow for alcohol consumption and drugs of abuse monitoring from one single blood droplet
14:15
to
14:30
Networking zone 1 (N1)
Marc Luginbühl
Oral presentation
Determinants for the effectiveness of an Online Ambulatory Service for Internet Addicts (OASIS)
14:15
to
14:30
Insights zone 2 (I2)
Laura Bottel
Oral presentation
Alcohol policies in Portugal: stakeholders' evaluation
14:15
to
14:30
Futures zone 3 (F3)
Hilson Cunnha Filho
Oral presentation
Drug use in rural and suburban environments: challenges in a progressive drug policy setting
14:15
to
14:30
Central square 3 (C3)
Ludmila Carapinha
14:20
Short communication
Have chronic cannabis consumers developed tolerance to the residual effects of recent cannabis use?
14:20
to
14:30
Networking zone 4 (N4)
Raimondo Bruno
14:30
Short communication
Sociodemographic and educational characteristics of cannabis users attending outpatient treatment centres: implications for psychoeducational intervention
14:30
to
14:40
Networking zone 4 (N4)
Samuel Rueda
Oral presentation
Application of a preliminary 'qualitative' leximetric approach via an example: anti-drug laws, policies and social outcomes in Italy since 2000.
14:30
to
14:45
Central square 3 (C3)
Carla Rossi
14:40
Short communication
Can cannabis use cause death in humans ?
14:40
to
14:50
Networking zone 4 (N4)
Mateja Jandl
15:10
Oral presentation
How have policies for legal medical and recreational cannabis shaped the development of new cannabis products?
15:10
to
15:25
Main stage
Wayne Hall
Oral presentation
Medical use of cannabis – a review of the regulatory frameworks and challenges
15:10
to
15:25
Central square 2 (C2)
Liesbeth Vandam
Oral presentation
Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands
15:10
to
15:25
Insights zone 4 (I4)
Daan van der Gouwe
15:25
Oral presentation
Changes in cannabis products during legal sales in Washington State
15:25
to
15:40
Main stage
Jonathan Caulkins
Oral presentation
Recreational cannabis legalisation in the Americas – design considerations and possible futures
15:25
to
15:40
Central square 2 (C2)
Beau Kilmer
15:40
Oral presentation
The International Cannabis Policy Study: comparing cannabis markets in Canada and US states with and without legal cannabis
15:40
to
15:55
Main stage
Elle Wadsworth
Oral presentation
CBD and other low-THC cannabis products, the latest health fad or serious drug policy challenge
15:40
to
15:55
Central square 2 (C2)
Brendan Hughes
Oral presentation
A descriptive analysis of the illicit supply of new psychoactive substances within and from China
15:40
to
15:55
Insights zone 4 (I4)
Minqi Zhao
15:55
Oral presentation
Changes in European cannabis resin: new evidence from THC and THC/CBD ratios in Denmark
15:55
to
16:10
Main stage
Kristine Rømer Thomsen
Oral presentation
Mobilising evidence-based secondary prevention for cannabis use in legalisation contexts: The Lower-Risk Cannabis Use Guidelines (LRCUG)
15:55
to
16:10
Central square 2 (C2)
Wayne Hall
Oral presentation
MDMA dosage in XTC tablets: size matters
15:55
to
16:10
Insights zone 4 (I4)
Ruben Vrolijk
16:10
Oral presentation
Health effects of new cannabis products in Europe
16:10
to
16:25
Main stage
Tom Freeman
Oral presentation
Key lessons for cannabis policy for the next decade
16:10
to
16:25
Central square 2 (C2)
Michael Farrell
Oral presentation
Understanding drug markets: results of the MARSTUP study
16:10
to
16:25
Insights zone 4 (I4)
Frank Zobel
16:50
Oral presentation
A community-based peer-driven program to reach people who inject drugs, monitor risk behaviours and 'test and treat' for infectious diseases in Athens, Greece: ARISTOTLE HCV-HIV
16:50
to
17:05
Futures zone 1 (F1)
Vana Sypsa
Oral presentation
Monitoring systems
16:50
to
18:20
Insights zone 1 (I1)
Mimmi Erikkson Tinghög
Oral presentation
National and regional coordination and initiative to achieve the objectives of the strategy
16:50
to
18:20
Insights zone 1 (I1)
Linda Brännström
Oral presentation
Assessing results of the ANDT strategy
16:50
to
18:20
Insights zone 1 (I1)
Jenny Hansson
17:00
Oral presentation
Interpreting wastewater data alongside other population-level indicators of stimulant use
17:00
to
17:15
Central square 2 (C2)
Hayley Jones
Oral presentation
Alcohol policy in the Netherlands: the National Prevention Agreement
17:00
to
17:15
Central square 1 (C1)
Dike van de Mheen
17:05
Oral presentation
Uptake of testing, linkage to care, and treatment for hepatitis C infection among people who inject drugs in Australia: the ETHOS Engage Study
17:05
to
17:20
Futures zone 1 (F1)
Jason Grebely
17:15
Oral presentation
What are the indirect causes of death among people who use drugs in Ireland? Findings from a comprehensive special register on drug related deaths
17:15
to
17:30
Central square 2 (C2)
Suzi Lyons
Oral presentation
Portuguese alcohol and health forum experience as an ecological approach to the alcohol related harms
17:15
to
17:30
Central square 1 (C1)
Alexandra Pinto
17:20
Oral presentation
Low HCV-RNA prevalence and low anti HCV incidence in a large national sample of PWID in opioid substitution treatment in Germany: a prospective cohort study
17:20
to
17:35
Futures zone 1 (F1)
Bernd Schulte
17:30
Oral presentation
Temporary and constant remission: a record-linkage study of a national cohort of people with psychoactive drug use disorders
17:30
to
17:45
Central square 2 (C2)
Morten Hesse
Oral presentation
'Suspending your licence to drink': insights from an innovative criminal justice program
17:30
to
17:45
Central square 1 (C1)
Beau Kilmer
17:35
Oral presentation
Monitoring the elimination of hepatitis C and B among people who inject drugs in Europe
17:35
to
17:50
Futures zone 1 (F1)
Thomas Seyler
17:45
Oral presentation
Effective policies to support autonomous attempts to quit opioid use - a cross-sectional study across 14 countries
17:45
to
18:00
Central square 2 (C2)
Larissa Maier
Oral presentation
Managers’ alcohol policy knowledge and inclination towards early alcohol interventions in the workplace: associations with sociodemographic, work-related and health characteristics
17:45
to
18:00
Central square 1 (C1)
Devy Elling
17:50
Oral presentation
'Towards eliminating viral hepatitis': A critical examination of the performativity of hepatitis C elimination goals and targets
17:50
to
18:05
Futures zone 1 (F1)
Kari Lancaster
18:00
Oral presentation
Alcohol intoxication management services in the night-time economy are highly acceptable to their users but they may not reduce demand on emergency services: a mixed methods study.
18:00
to
18:15
Central square 1 (C1)
Simon Moore
18:05
Oral presentation
Evidencing viral elimination futures: modelling, targets and the end of Hep C
18:05
to
18:20
Futures zone 1 (F1)
Tim Rhodes
18:30
Oral presentation
Babel and Bleak House; what ELDD can and can’t tell us about drug laws in 30 countries
18:30
to
19:30
Networking zone 1 (N1)
Brendan Hughes
Oral presentation
tba
18:30
to
19:30
Networking zone 1 (N1)
Scott Burris
18:40
Short communication
Recommendations for NPS-targeted initiatives in Belgium
18:40
to
18:50
Networking zone 3 (N3)
Anton van Dijck
Oral presentation
Use of an adapted version of the community readiness assessment to examine the current state of alcohol prevention in communities in Spain and Portugal
18:40
to
18:55
Central square 1 (C1)
Claudia Pischke
Oral presentation
Cannabis labelling and consumer understanding of THC levels and serving sizes.
18:40
to
18:55
Insights zone 4 (I4)
Samantha Goodman
18:50
Short communication
Predicting the onset of ketamine use among frequent nightlife attendees
18:50
to
19:00
Networking zone 3 (N3)
Charlotte van Miltenburg
18:55
Oral presentation
Building systems to promote prevention science: challenges and strategies
18:55
to
19:10
Central square 1 (C1)
Peer van der Kreeft
Oral presentation
The impact of cannabis health warning labels on risk awareness and behaviour
18:55
to
19:10
Insights zone 4 (I4)
Adam Winstock
19:00
Short communication
Why a zero tolerance drug policy for festivals is not working (well)
19:00
to
19:10
Networking zone 3 (N3)
Jochen Schrooten
19:10
Short communication
Towards gender-sensitive responses in the drugs field: Intersections between sexual violence, drug use in nightlife environments
19:10
to
19:20
Networking zone 3 (N3)
Cristiana Vale Pires
Oral presentation
Minimum quality standards in drug demand reduction - from policy consensus to assessment and implementation
19:10
to
19:25
Central square 1 (C1)
Matej Košir
Oral presentation
The efficacy of health warnings and package branding on perceptions of cannabis products among youth and young adults.
19:10
to
19:25
Insights zone 4 (I4)
Cesar Leos-Toro
19:20
Short communication
Setting up a HPLC in a 7-day psychedelic music festival: drug checking moving forward
19:20
to
19:30
Networking zone 3 (N3)
Daniel Martins
Friday, 25 October
09:10
Oral presentation
Presence and practices of cannabis social clubs within the European Union
09:10
to
09:25
Central square 1 (C1)
Mafalda Pardal
09:15
Oral presentation
Assessing the impact of laws controlling the online availability of 25I-NBOMe, AH-7921, MDPV and MXE – outcomes of a semi-automated e-shop monitoring. Drugs: education, prevention and policy
09:15
to
09:30
Central square 3 (C3)
Vendula Belackova
09:25
Oral presentation
Initial lessons and next steps for a public health approach to cannabis regulation in Canada
09:25
to
09:40
Central square 1 (C1)
Rebecca Jesseman
09:30
Oral presentation
Some constitutional issues regarding control of new psychoactive substances
09:30
to
09:45
Central square 3 (C3)
Krzysztof Krajewski
09:40
Oral presentation
Implementing cannabis regulation to achieve public health and safety goals in California – assessing the successes and challenges of the first year of regulation
09:40
to
09:55
Central square 1 (C1)
Jennifer Price
09:45
Oral presentation
Making the National Strategy on Addiction work for practitioners in addiction aid: how Swiss authorities and civil society bridge theory and practice
09:45
to
10:00
Central square 3 (C3)
Mirjam Weber
09:55
Oral presentation
Development of new measures of cannabis market exposure: a case study in Colorado
09:55
to
10:10
Central square 1 (C1)
Rosalie Pacula
10:00
Oral presentation
Leveraging citizen science and the power of civil society networks in a trans European mobile application
10:00
to
10:15
Central square 3 (C3)
Florian Scheibein
10:45
Supporting future cannabis policy/achieving a Standard Joint Unit – FuturiZe workshop
10:45
to
12:15
Futures zone 3 (F3)
Hugo López-Pelayo
Supporting future cannabis policy/achieving a Standard Joint Unit backcasting workshop workshop
10:45
to
12:15
Futures zone 3 (F3)
Antoni Gual
10:50
Oral presentation
Reitox: the European information network on drugs and drug addiction
10:50
to
11:00
Insights zone 2 (I2)
Sandrine Sleiman
10:55
Oral presentation
Evaluations of recreational cannabis legalisation in the US – overview and key lessons for policymakers
10:55
to
11:10
Networking zone 2 (N2)
Beau Kilmer
Oral presentation
Systematic review of untreated remission from alcohol problems: estimation lies in the eye of the beholder
10:55
to
11:10
Insights zone 1 (I1)
Richard Mellor
11:00
Oral presentation
Case study from Ireland: Use of data in public debate on alternative approaches to the possession of drugs for person use
11:00
to
11:15
Insights zone 2 (I2)
Brian Galvin
11:10
Oral presentation
Legalising cannabis for recreational purposes in Canada – practical challenges and opportunities for evaluating implementation and outcomes
11:10
to
11:25
Networking zone 2 (N2)
Rebecca Jesseman
Oral presentation
Assertive outreach for high-need, high-cost alcohol related frequent NHS hospital attenders: characteristics of participants in an RCT of assertive outreach treatment
11:10
to
11:25
Insights zone 1 (I1)
Andreas Kimergård
11:15
Oral presentation
Case study from Czech Republic: role of evidence in drug (de)criminalisation in the Czech Republic
11:15
to
11:30
Insights zone 2 (I2)
Viktor Mravčík
11:25
Oral presentation
The role of evaluation in the development of the EU approach on drugs
11:25
to
11:40
Networking zone 2 (N2)
Danilo Ballotta
Oral presentation
Applications of virtual reality and eye-tracking technologies in substance use disorders: the ALCO-VR project
11:25
to
11:40
Insights zone 1 (I1)
Alexandra Ghita
11:30
Oral presentation
Case study from France: Use of data in public debate on alternative approaches to the possession of drugs for person use
11:30
to
11:45
Insights zone 2 (I2)
Ivana Obradovic
11:40
Oral presentation
Developing a flexible support package for EU Member States: EMCDDA’s ‘realistic’ policy evaluation approach
11:40
to
11:55
Networking zone 2 (N2)
Nicola Singleton
Impact of the introduction and withdrawal of financial incentives on the delivery of alcohol screening and brief advice in English primary health care: an interrupted time series analysis
11:40
to
11:55
Insights zone 1 (I1)
Amy O’Donnell
11:45
Oral presentation
Decision-making and the use of evidence
11:45
to
12:05
Insights zone 2 (I2)
Alison Ritter